Insider Trading Alert - ALB, ZHNE And AGX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Jan. 30, 2015, 44 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $300.00 to $7,196,200.00.

Highlighted Stocks Traded by Insiders:

Albemarle (ALB) - FREE Research Report

Maine Douglas L, who is Director at Albemarle, bought 7,847 shares at $48.48 on Jan. 30, 2015. Following this transaction, the Director owned 30,000 shares meaning that the stake was boosted by 35.42% with the 7,847-share transaction.

The shares most recently traded at $47.48, down $1.00, or 2.11% since the insider transaction. Historical insider transactions for Albemarle go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 1,059
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 1,059
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 1,059

The average volume for Albemarle has been 1.8 million shares per day over the past 30 days. Albemarle has a market cap of $3.7 billion and is part of the basic materials sector and chemicals industry. Shares are down 19.74% year-to-date as of the close of trading on Friday.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals. The stock currently has a dividend yield of 2.3%. The company has a P/E ratio of 10.1. Currently, there are 7 analysts who rate Albemarle a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALB - FREE

TheStreet Quant Ratings rates Albemarle as a hold. Among the primary strengths of the company is its reasonable valuation levels, considering its current price compared to earnings, book value and other measures. At the same time, however, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Get the full Albemarle Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Zhone Technologies (ZHNE) - FREE Research Report

Norrod James D, who is President & CEO at Zhone Technologies, bought 10,000 shares at $1.44 on Jan. 30, 2015. Following this transaction, the President & CEO owned 60,000 shares meaning that the stake was boosted by 20% with the 10,000-share transaction.

The shares most recently traded at $1.79, up $0.35, or 19.55% since the insider transaction. Historical insider transactions for Zhone Technologies go as follows:

  • 4-Week # shares sold: 43,524
  • 12-Week # shares sold: 43,524
  • 24-Week # shares sold: 43,524

The average volume for Zhone Technologies has been 120,200 shares per day over the past 30 days. Zhone Technologies has a market cap of $60.1 million and is part of the technology sector and telecommunications industry. Shares are down 64.98% year-to-date as of the close of trading on Friday.

Zhone Technologies, Inc. designs, develops, manufactures, and sells communications network equipment for telecommunications, wireless, and cable operators worldwide.

Exclusive Offer: Get the latest Stock Analysis on ZHNE - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Argan (AGX) - FREE Research Report

Bosselmann Rainer H, who is Chairman of the Board and CEO at Argan, sold 2,235 shares at $32.00 on Jan. 30, 2015. Following this transaction, the Chairman of the Board and CEO owned 312,901 shares meaning that the stake was reduced by 0.71% with the 2,235-share transaction.

The shares most recently traded at $30.28, down $1.72, or 5.68% since the insider transaction. Historical insider transactions for Argan go as follows:

  • 4-Week # shares sold: 61,562
  • 12-Week # shares bought: 1,400
  • 12-Week # shares sold: 80,882
  • 24-Week # shares bought: 1,400
  • 24-Week # shares sold: 100,882

The average volume for Argan has been 87,600 shares per day over the past 30 days. Argan has a market cap of $466.9 million and is part of the industrial goods sector and materials & construction industry. Shares are down 9.6% year-to-date as of the close of trading on Friday.

Argan, Inc. developments, builds, operates, and maintains public and independent power generation utilities as well as providing telecommunications infrastructure services. The company has a P/E ratio of 14.1. Currently, there are no analysts who rate Argan a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AGX - FREE

TheStreet Quant Ratings rates Argan as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Argan Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries